HomeOwner SearchCategory Search
Visit USCOOligonucleotide-Based Drugs and Therapeutics: Preclinical and Clinical Considerations for Development By Nicolay Ferrari [at el] (9781118537336) 3
Text Registration
Copyright Title
Oligonucleotide-Based Drugs and Therapeutics: Preclinical and Clinical Considerations for Development By Nicolay Ferrari [at el] (9781118537336) 3
Status
Published
on 15 Aug 2018
Year of Creation
2018
Copyright Claimant
John Wiley and Sons, Inc
Registration Number
TX0008619085
on 15 Aug 2018Copyright Summary
The U.S. Copyright record (Registration Number: TX0008619085) dated 15 Aug 2018, pertains to an electronic file (eService) titled "Oligonucleotide-Based Drugs and Therapeutics: Preclinical and Clinical Considerations for Development By Nicolay Ferrari [at el] (9781118537336) 3" created in 2018. The copyright holder is John Wiley and Sons, Inc, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to John Wiley and Sons, Inc.
Application Details
Registration Number
TX0008619085
Registration Date
8/15/2018
Year of Creation
2018
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
John Wiley and Sons, Inc
Physical Description
Book, 553 p
First Publication Nation
United States
ISBN
9781118537336
Preexisting Material
Some previously published text
Notes
Material Matter Claimed Note: Compilation of individual contributions
Statements
Application Title Statement: Oligonucleotide-Based Drugs and Therapeutics: Preclinical and Clinical Considerations for Development By Nicolay Ferrari [at el] (9781118537336) 3
Author Statement: John Wiley and Sons, Inc employer for hire Domicile: United States Authorship: Compilation of individual contributions
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.